Latest News

Sweden’s Sobi debates sale of Partner Products business area

Sweden’s Sobi debates sale of Partner Products business area

Patheon acquires Roche’s manufacturing facility in South Carolina, US

Patheon acquires Roche’s manufacturing facility in South Carolina, US

Victorian Government receives funding for thunderstorm asthma research

Victorian Government receives funding for thunderstorm asthma research

Mylan wins court ruling for Copaxone 40mg/mL patents

Global generic and specialist pharmaceuticals company Mylan has won a US District Court Ruling with regards to its Copaxone 40mg/mL...

Mylan wins court ruling for Copaxone 40mg/mL patents

Onxeo and Institut Curie to study benefits of combining radiotherapy, DNA repair inhibitors and immunotherapy

French bio-pharmaceutical company Onxeo and the Institut Curie have collaborated to launch a series of studies aimed to investigate the benefits of combining radiotherapy, DNA repair inhibitors...

Onxeo and Institut Curie to study benefits of combining radiotherapy, DNA repair inhibitors and immunotherapy

Merus closes global strategic research collaboration with Incyte

Netherlands-based Immuno-oncology company Merus has closed its previously announced global strategic research collaboration with...

Merus closes global strategic research collaboration with Incyte

Domain Therapeutics signs GPCR licensing agreement with Alkermes

Biopharmaceutical company Domain Therapeutics has signed a licensing agreement for its G-protein-coupled receptors (GPCR) BioSens-All technology with Ireland-based Alkermes....

Domain Therapeutics signs GPCR licensing agreement with Alkermes

Melbourne scientists develop first therapeutic dental vaccine

Melbourne scientists develop first therapeutic dental vaccine

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug

Novimmune and Genentech enter exclusive licence agreement for rheumatoid arthritis drug

Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany

Takeda Pharmaceuticals has announced plans to invest more than €100m to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany....

Takeda to invest more than €100m in manufacturing plant for dengue vaccine in Germany

Pfizer drops €400m expansion plans of Grange Castle plant in Ireland

US drugmaker Pfizer has reportedly cancelled a planned €400m expansion of its plant at Grange Castle in Clondalkin, Dublin,...

Pfizer drops €400m expansion plans of Grange Castle plant in Ireland

Arrow Generiques signs agreement to purchase selects assets in France from Teva

Arrow Generiques, the French unit of Aurobindo Pharma, has signed an agreement to purchase select commercial products in France from...

Arrow Generiques signs agreement to purchase selects assets in France from Teva

Neovacs and 3P Biopharmaceuticals partner to manufacture IFNa

French company Neovacs and Spanish-based 3P Biopharmaceuticals have collaborated to manufacture interferon alpha (IFNα)....

Neovacs and 3P Biopharmaceuticals partner to manufacture IFNa

Teva receives European Commission approval for Trisenox indication extension

Teva Pharmaceutical Industries has obtained approval from the European Commission for an indication extension of Trisenox (arsenic trioxide)....

Teva receives European Commission approval for Trisenox indication extension

M&As this week: CiToxLAB, Sichuan Kelun Pharma

French-based pre-clinical services provider CiToxLAB Group has announced that it has acquired a pre-clinical contract research company known as...

M&As this week: CiToxLAB, Sichuan Kelun Pharma

Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma Corporation

US-based biopharmaceutical company Incyte Corporation has entered a distribution agreement for the commercialisation of its drug named Iclusig (ponatinib) in Greece with GENESIS...

Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma Corporation

Haiti launches cholera vaccination campaign

Haiti has launched an emergency cholera vaccination campaign, under which more than 800,000 affected by Hurricane Matthew last month will be...

Haiti launches cholera vaccination campaign

University of Adelaide researchers test drug that promises to prevent pre-term birth

Researchers at the University of Adelaide have conducted a successful drug test that shows early promises of preventing pre-term...

University of Adelaide researchers test drug that promises to prevent pre-term birth

Teva receives approval for generic Tribenzor in US

Teva Pharmaceutical Industries has secured approval for generic Tribenzor (olmesartan medoxomil, amlodipine and hydrochlorothiazide) tablets in the US and is in the last stages of launch preparation....

Teva receives approval for generic Tribenzor in US

MHRA grants US patients with one form of blood cancer access to investigational medicine

The Medicines Healthcare Products and Regulatory Agency (MHRA) has granted US-based patients with one form of blood cancer access to the investigational medicine, nivolumab, through the...

MHRA grants US patients with one form of blood cancer access to investigational medicine

NICE recommends treatment with 60mg of ticagrelor in post-heart attack patients

AstraZeneca has announced that National Institute of Health and Care Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending 60mg of ticagrelor with aspirin...

NICE recommends treatment with 60mg of ticagrelor in post-heart attack patients
cachename:Newscachekey:rd-137342983_-954009584_rd-1665407042_1857678299_rd-488908060_1460672566_ap1460672566_1857678299_1613048906